Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 215

1.

A combinational treatment of carotenoids decreases Aβ secretion in human neurons via β-secretase inhibition.

Sho M, Ichiyanagi N, Imaizumi K, Ishikawa M, Morimoto S, Watanabe H, Okano H.

Neurosci Res. 2019 Oct 10. pii: S0168-0102(19)30493-6. doi: 10.1016/j.neures.2019.10.006. [Epub ahead of print]

PMID:
31606373
2.

Overexpression of Cullin4A correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.

Nakade H, Migita K, Matsumoto S, Wakatsuki K, Kunishige T, Miyao S, Sho M.

Int J Clin Oncol. 2019 Sep 18. doi: 10.1007/s10147-019-01547-2. [Epub ahead of print]

PMID:
31535245
3.

Ischaemia-reperfusion injury with Pringle's maneuver induces unusually large von Willebrand factor multimers after hepatectomy.

Yoshikawa T, Nomi T, Sakai K, Hayakawa M, Hokuto D, Matsuo Y, Sho M, Matsumoto M.

Thromb Res. 2019 Sep 5;183:20-27. doi: 10.1016/j.thromres.2019.09.005. [Epub ahead of print]

PMID:
31518960
4.

Targeting claudin-4 enhances chemosensitivity of pancreatic ductal carcinomas.

Sasaki T, Fujiwara-Tani R, Kishi S, Mori S, Luo Y, Ohmori H, Kawahara I, Goto K, Nishiguchi Y, Mori T, Sho M, Kondo M, Kuniyasu H.

Cancer Med. 2019 Sep 9. doi: 10.1002/cam4.2547. [Epub ahead of print]

5.

A BISPECIFIC MOLECULE TARGETING CD40 AND TUMOR ANTIGEN MESOTHELIN ENHANCES TUMOR-SPECIFIC IMMUNITY.

Ye S, Cohen D, Belmar NA, Choi D, Tan SS, Sho M, Akamatsu Y, Kim H, Iyer R, Cabel JM, Lake MR, Song D, Harlan J, Zhang C, Fang Y, Wahl AF, Culp P, Hollenbaugh D, Chao DT.

Cancer Immunol Res. 2019 Aug 28. pii: canimm.0805.2018. doi: 10.1158/2326-6066.CIR-18-0805. [Epub ahead of print]

PMID:
31462409
7.

Selective TACE with irinotecan-loaded 40 μm microspheres and FOLFIRI for colorectal liver metastases: phase I dose escalation pharmacokinetic study.

Tanaka T, Sato T, Nishiofuku H, Masada T, Tatsumoto S, Marugami N, Otsuji T, Kanno M, Koyama F, Sho M, Kichikawa K.

BMC Cancer. 2019 Aug 1;19(1):758. doi: 10.1186/s12885-019-5862-3.

8.

Left-sided Portal Hypertension After Pancreaticoduodenectomy With Resection of the Portal Vein/Superior Mesenteric Vein Confluence in Patients With Pancreatic Cancer: A Project Study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Mizuno S, Kato H, Yamaue H, Fujii T, Satoi S, Saiura A, Murakami Y, Sho M, Yamamoto M, Isaji S.

Ann Surg. 2019 Jul 26. doi: 10.1097/SLA.0000000000003487. [Epub ahead of print]

PMID:
31356273
9.

Risk Factors and Risk Scores for Predicting Early Recurrence After Curative Gastrectomy in Patients with Stage III Gastric Cancer.

Wakatsuki K, Matsumoto S, Migita K, Kunishige T, Nakade H, Miyao S, Sho M.

J Gastrointest Surg. 2019 Jul 19. doi: 10.1007/s11605-019-04327-5. [Epub ahead of print]

PMID:
31325135
10.

Significance of Herpesvirus Entry Mediator Expression in Human Colorectal Liver Metastasis.

Sasaki Y, Hokuto D, Inoue T, Nomi T, Yoshikawa T, Matsuo Y, Koyama F, Sho M.

Ann Surg Oncol. 2019 Nov;26(12):3982-3989. doi: 10.1245/s10434-019-07625-z. Epub 2019 Jul 16.

PMID:
31313042
11.

Association of skeletal muscle loss with the long-term outcomes of esophageal cancer patients treated with neoadjuvant chemotherapy.

Kamitani N, Migita K, Matsumoto S, Wakatsuki K, Kunishige T, Nakade H, Miyao S, Sho M.

Surg Today. 2019 Jul 15. doi: 10.1007/s00595-019-01846-1. [Epub ahead of print]

PMID:
31309328
12.

A pancreatic mucinous cystic neoplasm undergoing intriguing morphological changes over time and associated with recurrent pancreatitis: A case report.

Shioyama E, Mitoro A, Ogawa H, Kubo T, Ozutsumi T, Kitagawa K, Yoshikawa M, Ueda S, Akahori T, Marugami NA, Hatakeyama K, Yamao J, Sho M, Ohbayashi C, Yoshiji H.

Medicine (Baltimore). 2019 Jul;98(28):e16435. doi: 10.1097/MD.0000000000016435.

13.

Significance of the inflammation-based prognostic score in recurrent pancreatic cancer.

Nakagawa K, Sho M, Akahori T, Nagai M, Nakamura K, Takagi T, Tanaka T, Nishiofuku H, Ohbayashi C, Kichikawa K, Ikeda N.

Pancreatology. 2019 Jul;19(5):722-728. doi: 10.1016/j.pan.2019.05.461. Epub 2019 May 23.

PMID:
31153778
14.

Postoperative Serum C-Reactive Protein Level Predicts Long-term Outcomes in Stage I Gastric Cancer.

Migita K, Matsumoto S, Wakatsuki K, Kunishige T, Nakade H, Miyao S, Sho M.

J Surg Res. 2019 Oct;242:323-331. doi: 10.1016/j.jss.2019.04.075. Epub 2019 May 23.

PMID:
31129241
15.

Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: a multi-centre propensity score-based analysis.

Nomi T, Hirokawa F, Kaibori M, Ueno M, Tanaka S, Hokuto D, Noda T, Nakai T, Ikoma H, Iida H, Komeda K, Ishizaki M, Hayami S, Eguchi H, Matsumoto M, Morimura R, Maehira H, Sho M, Kubo S.

Surg Endosc. 2019 May 15. doi: 10.1007/s00464-019-06812-z. [Epub ahead of print]

PMID:
31093748
16.

Targeting claudin-4 enhances CDDP-chemosensitivity in gastric cancer.

Nishiguchi Y, Fujiwara-Tani R, Sasaki T, Luo Y, Ohmori H, Kishi S, Mori S, Goto K, Yasui W, Sho M, Kuniyasu H.

Oncotarget. 2019 Mar 15;10(22):2189-2202. doi: 10.18632/oncotarget.26758. eCollection 2019 Mar 15.

17.

Long-term survival after adrenal metastasectomy from colorectal cancer: a report of two cases.

Tsujimoto A, Ueda T, Kuge H, Inoue T, Obara S, Nakamoto T, Sasaki Y, Nakamura Y, Koyama F, Sho M.

Surg Case Rep. 2019 Apr 15;5(1):61. doi: 10.1186/s40792-019-0611-z.

18.

Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients.

Aoki S, Motoi F, Murakami Y, Sho M, Satoi S, Honda G, Uemura K, Okada KI, Matsumoto I, Nagai M, Yanagimoto H, Kurata M, Fukumoto T, Mizuma M, Yamaue H, Unno M; Multicenter Study Group of Pancreatobiliary Surgery (MSG-PBS).

BMC Cancer. 2019 Mar 21;19(1):252. doi: 10.1186/s12885-019-5460-4.

19.

Anastomotic leakage following retrosternal pull-up.

Matsumoto S, Wakatsuki K, Migita K, Nakade H, Kunishige T, Miyao S, Sho M.

Langenbecks Arch Surg. 2019 May;404(3):335-341. doi: 10.1007/s00423-019-01765-2. Epub 2019 Mar 4.

PMID:
30830313
20.

Phase II Study of the Triple Combination Chemotherapy of SOXIRI (S-1/Oxaliplatin/Irinotecan) in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.

Akahori T, Sho M, Yanagimoto H, Satoi S, Nagai M, Nishiwada S, Nakagawa K, Nakamura K, Yamamoto T, Hirooka S, Yamaki S, Ikeda N.

Oncologist. 2019 Jun;24(6):749-e224. doi: 10.1634/theoncologist.2018-0900. Epub 2019 Jan 24.

21.

Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery.

Nagakawa Y, Sahara Y, Hosokawa Y, Murakami Y, Yamaue H, Satoi S, Unno M, Isaji S, Endo I, Sho M, Fujii T, Takishita C, Hijikata Y, Suzuki S, Kawachi S, Katsumata K, Ohta T, Nagakawa T, Tsuchida A.

Ann Surg Oncol. 2019 Jun;26(6):1629-1636. doi: 10.1245/s10434-018-07131-8. Epub 2019 Jan 4.

PMID:
30610555
22.

Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05).

Motoi F, Kosuge T, Ueno H, Yamaue H, Satoi S, Sho M, Honda G, Matsumoto I, Wada K, Furuse J, Matsuyama Y, Unno M; Study Group of Preoperative Therapy for Pancreatic Cancer (Prep) and Japanese Study Group of Adjuvant Therapy for Pancreatic cancer (JSAP).

Jpn J Clin Oncol. 2019 Feb 1;49(2):190-194. doi: 10.1093/jjco/hyy190.

PMID:
30608598
23.

Prognostic value of the fibrinogen-to-platelet ratio as an inflammatory and coagulative index in patients with gastric cancer.

Wakatsuki K, Matsumoto S, Migita K, Kunishige T, Nakade H, Miyao S, Sho M.

Surg Today. 2019 Apr;49(4):334-342. doi: 10.1007/s00595-018-1734-8. Epub 2018 Nov 8.

PMID:
30411155
24.

MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma.

Hirono S, Kawai M, Okada KI, Fujii T, Sho M, Satoi S, Amano R, Eguchi H, Mataki Y, Nakamura M, Matsumoto I, Baba H, Tani M, Kawabata Y, Nagakawa Y, Yamada S, Murakami Y, Shimokawa T, Yamaue H.

Trials. 2018 Nov 8;19(1):613. doi: 10.1186/s13063-018-3002-z.

25.

Liver Regeneration After Major Liver Resection for Hepatocellular Carcinoma in the Elderly.

Yasuda S, Nomi T, Hokuto D, Yoshikawa T, Matsuo Y, Sho M.

J Invest Surg. 2018 Nov 2:1-7. doi: 10.1080/08941939.2018.1517839. [Epub ahead of print]

PMID:
30388925
26.

Transition of serum cytokines following pancreaticoduodenectomy: A subsidiary study of JAPAN-PD.

Maeda H, Okada KI, Fujii T, Oba MS, Kawai M, Hirono S, Kodera Y, Sho M, Akahori T, Shimizu Y, Ambo Y, Kondo N, Murakami Y, Ohuchida J, Eguchi H, Nagano H, Sakamoto J, Yamaue H.

Oncol Lett. 2018 Nov;16(5):6847-6853. doi: 10.3892/ol.2018.9422. Epub 2018 Sep 7.

27.

A Comparison Between Plastic and Metallic Biliary Stent Placement in Patients Receiving Preoperative Neoadjuvant Chemoradiotherapy for Resectable Pancreatic Cancer.

Nakamura K, Sho M, Akahori T, Nagai M, Nishiwada S, Nakagawa K, Tanaka T, Kichikawa K, Tamamoto T, Hasegawa M, Mitoro A, Yoshiji H, Ikeda N.

World J Surg. 2019 Feb;43(2):642-648. doi: 10.1007/s00268-018-4820-6.

PMID:
30298284
28.

Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic Recurrence in Patients with Curatively Resected Pancreatic Adenocarcinoma.

Motoi F, Murakami Y, Okada KI, Matsumoto I, Uemura K, Satoi S, Sho M, Honda G, Fukumoto T, Yanagimoto H, Kinoshita S, Kurata M, Aoki S, Mizuma M, Yamaue H, Unno M; Multicenter Study Group of Pancreatobiliary Surgery (MSG-PBS).

World J Surg. 2019 Feb;43(2):634-641. doi: 10.1007/s00268-018-4814-4.

PMID:
30298281
29.

The Prognostic Significance of the Geriatric Nutritional Risk Index in Patients with Esophageal Squamous Cell Carcinoma.

Migita K, Matsumoto S, Wakatsuki K, Ito M, Kunishige T, Nakade H, Sho M.

Nutr Cancer. 2018 Nov-Dec;70(8):1237-1245. doi: 10.1080/01635581.2018.1512640. Epub 2018 Sep 20.

PMID:
30235009
30.

Risk Factors for Late-Onset Gastrointestinal Hemorrhage After Pancreatoduodenectomy for Pancreatic Cancer.

Nagai M, Sho M, Akahori T, Nishiwada S, Nakagawa K, Nakamura K, Tanaka T, Nishiofuku H, Kichikawa K, Ikeda N.

World J Surg. 2019 Feb;43(2):626-633. doi: 10.1007/s00268-018-4791-7.

PMID:
30225561
31.

A Novel Navigation for Laparoscopic Anatomic Liver Resection Using Indocyanine Green Fluorescence.

Nomi T, Hokuto D, Yoshikawa T, Matsuo Y, Sho M.

Ann Surg Oncol. 2018 Dec;25(13):3982. doi: 10.1245/s10434-018-6768-z. Epub 2018 Sep 14.

PMID:
30218249
32.

Prognostic factors for actual long-term survival in the era of multidisciplinary treatment for pancreatic ductal adenocarcinoma.

Nakagawa K, Akahori T, Nishiwada S, Nagai M, Nakamura K, Tanaka T, Tamamoto T, Ohbayashi C, Hasegawa M, Kichikawa K, Ikeda N, Sho M.

Langenbecks Arch Surg. 2018 Sep;403(6):693-700. doi: 10.1007/s00423-018-1709-7. Epub 2018 Sep 15.

PMID:
30218193
33.

A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study.

Motoi F, Satoi S, Honda G, Wada K, Shinchi H, Matsumoto I, Sho M, Tsuchida A, Unno M; Study Group of Preoperative therapy for Pancreatic cancer (PREP).

J Gastroenterol. 2019 Feb;54(2):194-203. doi: 10.1007/s00535-018-1506-7. Epub 2018 Sep 4.

PMID:
30182219
34.

A neuroendocrine carcinoma with a well-differentiated adenocarcinoma component arising in Barrett's esophagus: a case report and literature review.

Doi S, Matsumoto S, Wakatsuki K, Migita K, Ito M, Kunishige T, Nakade H, Hatakeyama K, Ohbayashi C, Sho M.

Surg Case Rep. 2018 Aug 29;4(1):103. doi: 10.1186/s40792-018-0511-7.

35.

Short-term outcomes of endoscopic submucosal dissection versus laparoscopic surgery for colorectal neoplasms: An observational study.

Inoue T, Koyama F, Kuge H, Ueda T, Obara S, Nakamoto T, Sasaki Y, Nakamura Y, Sho M.

J Anus Rectum Colon. 2018 Jul 30;2(3):97-102. doi: 10.23922/jarc.2017-027. eCollection 2018.

36.

Predictive Factors for Delayed Gastric Emptying after Distal Gastrectomy with Roux-en-Y Reconstruction.

Matsumoto S, Wakatsuki K, Migita K, Ito M, Nakade H, Kunishige T, Kitano M, Nakatani M, Sho M.

Am Surg. 2018 Jun 1;84(6):1086-1090.

PMID:
29981653
37.

Anal gland adenocarcinoma in situ with pagetoid spread: a case report.

Ishioka K, Koyama F, Kuge H, Inoue T, Obara S, Nakamoto T, Sasaki Y, Nakamura Y, Takeda M, Ohbayashi C, Kuwahara M, Sho M.

Surg Case Rep. 2018 Jun 25;4(1):63. doi: 10.1186/s40792-018-0469-5.

38.

Clinical impact of developing better practices at the institutional level on surgical outcomes after distal pancreatectomy in 1515 patients: Domestic audit of the Japanese Society of Pancreatic Surgery.

Satoi S, Yamamoto T, Motoi F, Matsumoto I, Yoshitomi H, Amano R, Tahara M, Murakami Y, Arimitsu H, Hirono S, Sho M, Ryota H, Ohtsuka M, Unno M, Takeyama Y, Yamaue H.

Ann Gastroenterol Surg. 2018 Mar 25;2(3):212-219. doi: 10.1002/ags3.12066. eCollection 2018 May.

39.

LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug Conjugates.

Purcell JW, Tanlimco SG, Hickson J, Fox M, Sho M, Durkin L, Uziel T, Powers R, Foster K, McGonigal T, Kumar S, Samayoa J, Zhang D, Palma JP, Mishra S, Hollenbaugh D, Gish K, Morgan-Lappe SE, Hsi ED, Chao DT.

Cancer Res. 2018 Jul 15;78(14):4059-4072. doi: 10.1158/0008-5472.CAN-18-0327. Epub 2018 May 15.

40.

Von Willebrand Factor Aggravates Hepatic Ischemia-Reperfusion Injury by Promoting Neutrophil Recruitment in Mice.

Urisono Y, Sakata A, Matsui H, Kasuda S, Ono S, Yoshimoto K, Nishio K, Sho M, Akiyama M, Miyata T, Okuchi K, Nishimura S, Sugimoto M.

Thromb Haemost. 2018 Apr;118(4):700-708. doi: 10.1055/s-0038-1636529. Epub 2018 Apr 4.

PMID:
29618155
41.

Prognostic Significance of the Prognostic Nutritional Index in Patients with Recurrent Esophageal Squamous Cell Carcinoma.

Nakatani M, Migita K, Matsumoto S, Wakatsuki K, Ito M, Nakade H, Kunishige T, Kitano M, Sho M.

Nutr Cancer. 2018 Apr;70(3):467-473. doi: 10.1080/01635581.2018.1445771. Epub 2018 Mar 12.

PMID:
29528703
42.

K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma.

Sekita-Hatakeyama Y, Nishikawa T, Takeuchi M, Morita K, Takeda M, Hatakeyama K, Nakai T, Uchiyama T, Itami H, Fujii T, Mitoro A, Sho M, Ohbayashi C.

PLoS One. 2018 Mar 1;13(3):e0193692. doi: 10.1371/journal.pone.0193692. eCollection 2018.

43.

Significance of bacterial culturing of prophylactic drainage fluid in the early postoperative period after liver resection for predicting the development of surgical site infections.

Ishioka K, Hokuto D, Nomi T, Yasuda S, Yoshikawa T, Matsuo Y, Akahori T, Nishiwada S, Nakagawa K, Nagai M, Nakamura K, Ikeda N, Sho M.

Surg Today. 2018 Jun;48(6):625-631. doi: 10.1007/s00595-018-1629-8. Epub 2018 Jan 29.

PMID:
29380135
44.

Does anatomic resection improve the postoperative outcomes of solitary hepatocellular carcinomas located on the liver surface?

Hokuto D, Nomi T, Yasuda S, Yoshikawa T, Ishioka K, Yamada T, Takahiro A, Nakagawa K, Nagai M, Nakamura K, Kanehiro H, Sho M.

Surgery. 2018 Feb;163(2):285-290. doi: 10.1016/j.surg.2017.08.024. Epub 2017 Nov 28.

PMID:
29191676
45.

Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic ductal adenocarcinoma? -Multicenter surgical group study.

Yamamoto T, Satoi S, Kawai M, Motoi F, Sho M, Uemura KI, Matsumoto I, Honda G, Okada KI, Akahori T, Toyama H, Kurata M, Yanagimoto H, Yamaue H, Unno M, Kon M, Murakami Y.

Pancreatology. 2018 Jan;18(1):106-113. doi: 10.1016/j.pan.2017.11.005. Epub 2017 Nov 14.

PMID:
29153701
46.

Reinforced staplers for distal pancreatectomy.

Kawai M, Hirono S, Okada KI, Satoi S, Yanagimoto H, Kon M, Murakami Y, Kondo N, Sho M, Akahori T, Toyama H, Fukumoto T, Fujii T, Matsumoto I, Eguchi H, Ikoma H, Takeda Y, Fujimoto J, Yamaue H.

Langenbecks Arch Surg. 2017 Dec;402(8):1197-1204. doi: 10.1007/s00423-017-1634-1. Epub 2017 Nov 4.

PMID:
29103084
47.

Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells.

Ye S, Fox MI, Belmar NA, Sho M, Chao DT, Choi D, Fang Y, Zhao V, Keller SF, Starling GC, Culp PA.

J Immunol Res. 2017;2017:5737159. doi: 10.1155/2017/5737159. Epub 2017 Sep 17.

48.

Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis.

Hokuto D, Nomi T, Yasuda S, Yoshikawa T, Ishioka K, Yamada T, Akahori T, Nakagawa K, Nagai M, Nakamura K, Obara S, Kanehiro H, Sho M.

World J Surg. 2018 Mar;42(3):884-891. doi: 10.1007/s00268-017-4195-0.

PMID:
28879511
49.

The prognostic significance of inflammation-based markers in patients with recurrent gastric cancer.

Migita K, Matsumoto S, Wakatsuki K, Ito M, Kunishige T, Nakade H, Kitano M, Nakatani M, Sho M.

Surg Today. 2018 Mar;48(3):282-291. doi: 10.1007/s00595-017-1582-y. Epub 2017 Aug 23.

PMID:
28836056
50.

Long-term observation and treatment of a widespread intraductal papillary neoplasm of the bile duct extending from the intrapancreatic bile duct to the bilateral intrahepatic bile duct: A case report.

Hokuto D, Nomi T, Yasuda S, Yoshikawa T, Ishioka K, Yamada T, Akahori T, Nakagawa K, Nagai M, Nakamura K, Obara S, Kanehiro H, Sho M.

Int J Surg Case Rep. 2017;38:166-171. doi: 10.1016/j.ijscr.2017.07.031. Epub 2017 Jul 23.

Supplemental Content

Support Center